Astellas' first-in-class CLDN18.2 drug Vyloy has cleared the FDA. After a positive phase 3 readout, Otsuka is targeting an ...
Treatment MarketThe global castration-resistant prostate cancer (CRPC) treatment market is poised for substantial growth, ...
Sanofi and CD&R entered into exclusive negotiations for the potential sale and purchase of a 50% controlling stake in Opella.
Updated guidance from health technology assessment (HTA) agency NICE has concluded that Boston Scientific's HeartLogic and ...
The CRISPR specialist said that a single 50mg infusion of NTLA-2002 – which switches off a gene involved in the potentially ...
Prime Minister Narendra Modi today said this is the right time to join India's growth story, as German Chancellor Olaf Scholz met the Prime Minister in the national capital with a business delegation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback